ema retatrutide approval Triple Hormone Receptor Agonist: Mechanism, Evidence, and UK Status – Bolt Pharmacy Retatrutide vs CagriSema: The Battle

In humans, where C-cell GIP receptor expression appears to be lower, this effect may be minimal GIP and thyroid blood flow: Some preclinical data suggest GIP influences thyroid gland blood flow, which could theoretically affect hormone production and levothyroxine absorption in patients with remaining thyroid tissue No adverse thyroid effects in trials: In the SURMOUNT and SURPASS clinical trials, tirzepatide did not produce clinically significant changes in thyroid function tests in participants with normal thyroid function The presence of GIP receptors on thyroid tissue is an area of active research

To efficiently utilize the above-mentioned mechanisms for drug delivery across the BBB, further surface modification of liposomes is required

A varied microbiome fed by diverse prebiotics not a single "magic" strain or an enormous CFU number is what the research points toward for metabolic health

Presented for research literature review only Xie J et al